NCT06461000 EULAR Impact of Rheumatic and Musculoskeletal Diseases Survey
| NCT ID | NCT06461000 |
| Status | Recruiting |
| Phase | — |
| Sponsor | European Alliance of Associations in Rheumatology |
| Condition | Rheumatologic Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-06-12 |
| Primary Completion | 2028-06-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2025-06-12 with a primary completion date of 2028-06-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The EULAR Impact of RMDs Survey collects first-hand information about the impact of rheumatic and musculoskeletal diseases (RMDs) among patients across and beyond Europe. Through periodic questionnaires, patients will provide information about their healthcare situation, and how the disease affects their social and occupational lives. This data will be an important resource for researchers, healthcare professionals, and patients alike, providing valuable insights into the burden of disease and helping improve the overall care for people living with these conditions.
Eligibility Criteria
Inclusion Criteria: * 18-year-old at time of baseline survey * Living in a EULAR country at time of baseline survey * Diagnosed with at least one RMD * Valid personal e-mail address * Being able to use an internet website Exclusion Criteria: * none
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06461000 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Rheumatologic Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06461000 currently recruiting?
Yes, NCT06461000 is actively recruiting participants. Contact the research team at coralie.signorell@eular.org for enrollment information.
Where is the NCT06461000 trial being conducted?
This trial is being conducted at Kilchberg, Switzerland.
Who is sponsoring the NCT06461000 clinical trial?
NCT06461000 is sponsored by European Alliance of Associations in Rheumatology. The trial plans to enroll 1,000 participants.